Skip to main content
Contact Us
Subscribe
E-Edition
64°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
2025 Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about PTGX
Recent news which mentions PTGX
< Previous
1
2
3
4
Next >
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
April 14, 2022
Tickers
AGRX
AIM
AIRG
APLD
Tags
Market News
LMND
SONM
From
InvestorPlace
FDA Intends To Revoke Protagonist Therapeutics' Rusfertide Breakthrough Tag In Rare Form Of Blood Cancer
April 14, 2022
Tickers
PTGX
Tags
FDA
Small Cap
General
From
Benzinga
Protagonist Therapeutics Earns $25M Milestone Payment From Janssen Biotech
March 16, 2022
Tickers
JNJ
PTGX
Tags
Biotech
Benzinga
Briefs
From
Benzinga
Protagonist Therapeutics's Return On Capital Employed Overview
March 03, 2022
Tickers
PTGX
Tags
BZI/ROCE
PTGX
Benzinga
From
Benzinga
3 Desirable Drug Stocks With Very Promising Pipelines
February 16, 2022
Tickers
AGIO
BMY
HRMY
JNJ
Tags
Market News
NASDAQ:HRMY,NASDAQ:SDGR,NASDAQ:PTGX,NYSEARCA:XBI,NASDAQ:SNY,NYSE:BMY,NASDAQ:AGIO,NYSE:JNJ
BMY
From
InvestorPlace
The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More
December 06, 2021
Tickers
ABBV
ADCT
AGIO
ALNY
Tags
KROS
RETA
Top Stories
From
Benzinga
Protagonist To Go Ahead With Oral Peptide PN-235, Discontinues Phase 1 Candidate
December 03, 2021
Tickers
JNJ
PTGX
Tags
Benzinga
Movers
Biotech
From
Benzinga
The Daily Biotech Pulse: Protagonist Pulls Plug On Phase 1 Asset, Xenon Aces Mid-Stage Epilepsy Study, Esperion Prices Offering
December 03, 2021
Tickers
BGNE
BMY
ESPR
IBB
Tags
Offerings
BGNE
Market News
From
Benzinga
What 9 Analyst Ratings Have To Say About Protagonist Therapeutics
November 15, 2021
Tickers
PTGX
Tags
Market News
Benzinga
PTGX
From
Benzinga
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
November 08, 2021
Tickers
ABUS
ACAD
ACIU
ADAP
Tags
GRAY
IPOs
General
From
Benzinga
Why Protagonist Therapeutics Stock Skyrocketed 80.2% Last Month
November 08, 2021
Tickers
PTGX
Tags
Market News
Recent Press Releases
PTGX
From
Motley Fool
5 Short Squeeze Candidates To Watch: Progenity Tops List Again, Augmented Reality Play WiMi Hologram Joins List
November 01, 2021
Tickers
AMC
ASLE
BTBT
GLG
Tags
Market News
BTBT
ASLE
From
Benzinga
Short Squeeze Stocks: PTGX, AGC and 3 Others Experts Think Are Ready to Pop
October 25, 2021
Tickers
AGC
DBGI
PALT
PROG
Tags
Uncategorized
NASDAQ:PROG,NASDAQ:DBGI,NASDAQ:PTGX,NASDAQ:AGC,NASDAQ:PALT
DBGI
From
InvestorPlace
5 Short Squeeze Candidates To Watch: Progenity, Digital Brands Top List Again, SPAC AGC Joins Ahead Of Merger
October 25, 2021
Tickers
AGC
AMC
DBGI
GME
Tags
Short Squeeze
Trading Ideas
Market News
From
Benzinga
The Daily Biotech Pulse: Athira CEO Resigns Over Doctored Research, Merck's Keytruda Snags First Approval For Breast Cancer In Europe, Minerva And Xilio IPOs
October 22, 2021
Tickers
ADPT
ATHA
AVRO
IBB
Tags
IPOs
General
Biotech
From
Benzinga
The Week Ahead In Biotech (Oct. 18-23): J&J, Biogen Kickstart Big Pharma Earnings, Regeneron-Sanofi, Roche Await FDA Decisions And IPOs
October 18, 2021
Tickers
ABEO
ABT
AVDL
AVRO
Tags
Market News
BIIB
TNYA
From
Benzinga
Ten stocks worth watching next week
October 16, 2021
Tickers
AA
ADMP
FCEL
MFH
Tags
MFH
OEG
AA
From
AC Investor Blog
What 10 Analyst Ratings Have To Say About Protagonist Therapeutics
October 13, 2021
Tickers
PTGX
Tags
Analyst Ratings
BZI/AAR
PTGX
From
Benzinga
10 Biggest Price Target Changes For Wednesday
October 13, 2021
Tickers
CLR
GPK
HUBS
PTGX
Tags
Price Target
RVNC
SGH
From
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
October 12, 2021
Tickers
ENZ
ICVX
IKNA
INBX
Tags
INBX
ORGO
IKNA
From
Benzinga
Analyst Ratings For Protagonist Therapeutics
October 12, 2021
Tickers
PTGX
Tags
Analyst Ratings
BZI/AAR
PTGX
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2021
October 12, 2021
Tickers
ABNB
ACT
ADM
ADMS
Tags
LIFE
AMP
ALV
From
Benzinga
10 Biggest Price Target Changes For Tuesday
October 12, 2021
Tickers
ALV
AYI
FLXN
LEA
Tags
Biotechnology
Information Technology
MGM
From
Benzinga
46 Biggest Movers From Yesterday
October 12, 2021
Tickers
ACY
ADMS
AMPY
ANY
Tags
FLXN
USWS
Markets
From
Benzinga
Mid-Afternoon Market Update: Dow Tumbles Over 100 Points; Flexion Therapeutics Shares Spike Higher
October 11, 2021
Tickers
ADMS
CENX
CIFR
FLXN
Tags
Markets
FLXN
Market News
From
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
October 11, 2021
Tickers
ADMS
CCRN
EFTR
FLXN
Tags
NAOV
OCUL
EFTR
From
Benzinga
Where Protagonist Therapeutics Stands With Analysts
October 11, 2021
Tickers
PTGX
Tags
Market News
Benzinga
PTGX
From
Benzinga
DQ Stock: Why One Analyst Is Making Daqo New Energy Its Top Solar Pick
October 11, 2021
Tickers
DQ
LUV
PTGX
SOFI
Tags
NYSE:DQ,NASDAQ:SOFI,NYSE:LUV,NASDAQ:PTGX
Market News
PTGX
From
InvestorPlace
Solar Stocks: Why SUNW, SPWR, DQ, ENPH and SEDG Are Shining Bright Today
October 11, 2021
Tickers
DQ
ENPH
LUV
PTGX
Tags
Today's Market
SPWR
DQ
From
InvestorPlace
Mid-Day Market Update: Crude Oil Surges Over 2%; Supernus Pharmaceuticals To Acquire Adamas Pharmaceuticals
October 11, 2021
Tickers
ADMS
CENX
FLXN
HYLN
Tags
Commodities
Benzinga
Intraday Update
From
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.